Preclinical Assessment of Gene Therapy for Ventricular Arrhythmia [ 2017 - 2019 ]

Research Grant

Researchers: Dr Eddy Kizana (Principal investigator) ,  Dr James Chong ,  Prof Ian Alexander

Brief description Up to 10% of patients are at risk of sudden death following myocardial infarction. Current treatment and preventative initiatives have their limits and are not without risk. In this proposal we will continue to develop an exciting new treatment approach using gene therapy technology. We will attempt to overcome some of the barriers for human application of this technology and pave the way for early phase clinical trials.

Funding Amount $AUD 819,687.61

Funding Scheme Project Grants

Notes Standard Project Grant